Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: February 2, 2023

Pliva Hrvatska Doo Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for PLIVA HRVATSKA DOO, and what generic and branded alternatives to PLIVA HRVATSKA DOO drugs are available?

PLIVA HRVATSKA DOO has seven approved drugs.

There are four tentative approvals on PLIVA HRVATSKA DOO drugs.

Summary for Pliva Hrvatska Doo

US Patents:	0
Tradenames:	6
Ingredients:	6
NDAs:	7
Drug Master File Entries:	1

Drugs and US Patents for Pliva Hrvatska Doo

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pliva Hrvatska Doo	VENLAFAXINE HYDROCHLORIDE	venlafaxine hydrochloride	TABLET;ORAL	078517-004	Jun 13, 2008		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Pliva Hrvatska Doo	PRAVASTATIN SODIUM	pravastatin sodium	TABLET;ORAL	077730-002	Nov 21, 2006		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Pliva Hrvatska Doo	TOPIRAMATE	topiramate	TABLET;ORAL	077905-002	Mar 30, 2009		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Pliva Hrvatska Doo	ONDANSETRON HYDROCHLORIDE	ondansetron hydrochloride	TABLET;ORAL	077112-003	Jun 25, 2007		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

Harvard Business School

Merck

AstraZeneca

Moodys

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.